The first classification on this topic categorized cardiomyopathies as heart muscle diseases
with dilated (DCM), hypertrophic, restrictive, arrhythmogenic right ventricular (ARVC), or …

Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could be
challenging since there is not one single test able to achieve an accurate diagnosis. The …

Background—This study was designed to assess the epidemiology, characteristics, and
outcome of cardiac sarcoidosis (CS) in Finland. Methods and Results—We identified in …

Objectives: This study aimed to demonstrate that the presence of late gadolinium
enhancement (LGE) is a predictor of death and other adverse events in patients with …

This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Background Cardiac positron emission tomography (PET) using 18 F-fluorodeoxyglucose
(FDG) has been used to diagnose and monitor cardiac sarcoidosis (CS). It is not known …

Background There are no published clinical consensus guidelines or systematic evaluation
supporting the use of corticosteroids for the treatment of cardiac sarcoidosis. The purpose of …

Restrictive cardiomyopathies (RCMs) are a diverse group of myocardial diseases with a
wide range of aetiologies, including familial, genetic and acquired diseases and ranging …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Sarcoidosis is a multisystem disorder of unknown cause, and cardiac sarcoidosis affects at
least 25% of patients and accounts for substantial mortality and morbidity from this disease …